Dividend Overview
Dividend Yield
3.89%
Dividend / Share
$0.65
Takeda Pharmaceutical Company
Exchange: NYSESector: HealthcareIndustry: Drug Manufacturers - Specialty & Generic
Values in USD · ADR · Reports in JPY
Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R&D-driven biopharmaceutical company headquartered in Japan, we are guided by our commitment to patients, our people and the planet. Our employees in approximately 80 countries and regions are driven by our purpose and are grounded in the values that have defined us for more than two centuries.
Current Price
$16.68
+0.60%GoodMoat Value
$44.87
169.0% undervaluedProfile
Valuation (TTM)
Market Cap$52.11B
P/E73.27
EV—
P/B1.12
Shares Out3.12B
P/Sales1.75
Revenue$29.80B
EV/EBITDA9.47
Takeda Pharmaceutical Company (TAK) Dividends
Key Metrics
Market Cap
$52.11B
P/E Ratio
73.27
Forward P/E
—
EPS
$0.23
PEG Ratio
0.21
Book Value
$14.87
Dividend Yield
3.89%
Profit Margin
2.53%
ROE
1.62%
Dividend History
Dividend Safety
TAK Dividend Analysis
Takeda Pharmaceutical Company (TAK) dividend analysis including yield, payout history, and sustainability metrics. The current dividend yield is 3.89%. The annual dividend per share is $0.65.
P/E ratio: 73.27. Profit margin: 2.53%. Free cash flow: $5.44B. This page shows Takeda Pharmaceutical Company's dividend overview, key metrics, historical payout data, and dividend safety assessment to help income-focused investors evaluate the sustainability of dividend payments.
GoodMoat's dividend analyzer evaluates payout ratios, earnings coverage, and free cash flow coverage to determine how well supported Takeda Pharmaceutical Company's dividend payments are. Use this analysis alongside the company's financial statements and quality score to make informed income-investing decisions.